Clinical outcome and risk factors for recurrence in borderline ovarian tumours (Q36614311)

15 August 2017

Clinical outcome and risk factors for recurrence in borderline ovarian tumours (English)

1 reference

15 August 2017

Yokoyama Y

1

1 reference

15 August 2017

Moriya T

2

1 reference

15 August 2017

Takano T

3

1 reference

15 August 2017

Shoji T

4

1 reference

15 August 2017

Takahashi O

5

1 reference

15 August 2017

Nakahara K

6

1 reference

15 August 2017

Yamada H

7

1 reference

15 August 2017

Yaegashi N

8

1 reference

15 August 2017

Okamura K

9

1 reference

15 August 2017

Izutsu T

10

1 reference

15 August 2017

Sugiyama T

11

1 reference

15 August 2017

Tanaka T

12

1 reference

15 August 2017

Kurachi H

13

1 reference

15 August 2017

Sato A

14

1 reference

15 August 2017

Tase T

15

1 reference

15 August 2017

Mizunuma H

16

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

94

1 reference

15 August 2017

11

1 reference

15 August 2017

1586-1591

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603139

15 August 2017

0 references

cites work

Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361313

Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361313

Surgical staging in patients with ovarian tumors of low malignant potential

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361313

Surgery for borderline tumor of the ovary

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361313

Outcome and reproductive function after conservative surgery for borderline ovarian tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361313

Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361313

A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361313

Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361313

Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361313

Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361313

Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361313

Changes in definitions of clinical staging for carcinoma of the cervix and ovary: International Federation of Gynecology and Obstetrics

20 September 2018

1 reference

12 December 2020

Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors

1 reference

12 December 2020

Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study

1 reference

12 December 2020

Long-term survival and patterns of care in women with ovarian tumors of low malignant potential

1 reference

12 December 2020

Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies

1 reference

12 December 2020

Safety of conservative management and fertility outcome in women with borderline tumors of the ovary

1 reference

12 December 2020

Low malignant potential tumors of the ovary: a study of 76 cases

1 reference

12 December 2020

Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis

1 reference

12 December 2020

Serous borderline tumors of the ovary. A clinicopathologic, immunohistochemical, and quantitative study of 44 cases

1 reference

12 December 2020

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6603139

1 reference

15 August 2017

1 reference

15 August 2017

1 reference